Taiwan FDA registration 300425cbb8d91708ae4d82a26deb33b9

"Leica" Novocastra Liquid Mouse Monoclonal Antibody Helicobacter pylori (Non-Sterile)

TW: "錸卡"諾摩凱斯特老鼠抗人類幽門桿菌單株抗體(未滅菌)
Taiwan flagTaiwan·Risk Class 1·MD·LEICA BIOSYSTEMS NEWCASTLE LTD.·Registered Dec 12, 2017 – Dec 12, 2022Expired
Registration details
Analysis ID
300425cbb8d91708ae4d82a26deb33b9
License Form
Ministry of Health Medical Device Import No. 018598
Customs Code
DHA09401859804
Company information
Manufacturer Country
United Kingdom
Product details
Intended Use
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
Product Type (Level 1)
B Hematology and pathology devices
Product Type (Level 2)
B1860 Immunopathological histochemical reagents and kits
Import Information
Imported from abroad
Dates and status
Registration Date
Dec 12, 2017
Expiry Date
Dec 12, 2022
About this record

Access comprehensive regulatory information for "Leica" Novocastra Liquid Mouse Monoclonal Antibody Helicobacter pylori (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 300425cbb8d91708ae4d82a26deb33b9 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI89,000+ Devices